These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22483421)

  • 1. Additive impact of diabetes mellitus on patients with metabolic syndrome and acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lee MG; Jeong MH; Ahn Y; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Seung KB; Park SJ;
    Int J Cardiol; 2012 May; 157(2):283-5. PubMed ID: 22483421
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct transfer of ST-elevation myocardial infarction patients for primary percutaneous coronary intervention from short and long transfer distances decreases temporal delays and improves short-term prognosis: the PROGALIAM Registry.
    Estévez-Loureiro R; Calviño-Santos R; Vázquez-Rodríguez JM; Marzoa-Rivas R; Barge-Caballero E; Salgado-Fernández J; Aldama-López G; Barreiro-Díaz M; Varela-Portas J; Freire-Tellado M; Vázquez-González N; Castro-Beiras A
    EuroIntervention; 2010 Aug; 6(3):343-9. PubMed ID: 20884412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention.
    Marenzi G; De Metrio M; Rubino M; Lauri G; Cavallero A; Assanelli E; Grazi M; Moltrasio M; Marana I; Campodonico J; Discacciati A; Veglia F; Bartorelli AL
    Am Heart J; 2010 Dec; 160(6):1170-7. PubMed ID: 21146674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of initial thrombolysis in myocardial infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a National Registry of Myocardial Infarction-5 (NRMI-5) analysis.
    Wu J; Pride YB; Frederick PD; Gibson CM
    Am Heart J; 2011 Jul; 162(1):178-83. PubMed ID: 21742106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the Croatian Primary Percutaneous Coronary Intervention Network for patients with ST-segment elevation acute myocardial infarction.
    Nikolić Heitzler V; Babic Z; Milicic D; Bergovec M; Raguz M; Mirat J; Strozzi M; Plazonic Z; Giunio L; Steiner R; Starcevic B; Vukovic I
    Am J Cardiol; 2010 May; 105(9):1261-7. PubMed ID: 20403476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry.
    McCabe JM; Armstrong EJ; Hoffmayer KS; Bhave PD; MacGregor JS; Hsue P; Stein JC; Kinlay S; Ganz P
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):672-9. PubMed ID: 22949494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
    Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Jackson EA; Moscucci M; Smith DE; Share D; Dixon S; Greenbaum A; Grossman PM; Gurm HS
    Am Heart J; 2011 Jan; 161(1):106-112.e1. PubMed ID: 21167341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction.
    Claeys MJ; de Meester A; Convens C; Dubois P; Boland J; De Raedt H; Vranckx P; Coussement P; Gevaert S; Sinnaeve P; Evrard P; Beauloye C; Renard M; Vrints C
    Arch Intern Med; 2011 Mar; 171(6):544-9. PubMed ID: 21444843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ
    Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
    Stebbins A; Mehta RH; Armstrong PW; Lee KL; Hamm C; Van de Werf F; James S; Toftegaard-Nielsen T; Seabra-Gomes R; White HD; Granger CB;
    Circ Cardiovasc Interv; 2010 Oct; 3(5):414-22. PubMed ID: 20858863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of manual versus mechanical thrombus removal in primary percutaneous coronary intervention in the treatment of ST-segment elevation myocardial infarction (TREAT-MI).
    Vink MA; Patterson MS; van Etten J; Ijsselmuiden AJ; Dirksen MT; Amoroso G; Slagboom T; Laarman G; Kiemeneij F
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):14-9. PubMed ID: 21681888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
    Baron SJ; Giugliano RP
    Am J Cardiol; 2011 Apr; 107(7):1001-9. PubMed ID: 21256466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial.
    Palmerini T; Mehran R; Dangas G; Nikolsky E; Witzenbichler B; Guagliumi G; Dudek D; Genereux P; Caixeta A; Rabbani L; Weisz G; Parise H; Fahy M; Xu K; Brodie B; Lansky A; Stone GW
    Circulation; 2011 Jun; 123(24):2829-37, 7 p following 2837. PubMed ID: 21632496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender disparity in 48-hour mortality is limited to emergency percutaneous coronary intervention for ST-elevation myocardial infarction.
    Roncalli J; Elbaz M; Dumonteil N; Boudou N; Lairez O; Lhermusier T; Chilon T; Baixas C; Galinier M; Puel J; Fauvel JM; Carrié D; Ruidavets JB
    Arch Cardiovasc Dis; 2010 May; 103(5):293-301. PubMed ID: 20619239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.